How L1 Capital’s Anteris Sell‑Off Signals a Strategic Rebalancing in Health‑Tech
How L1 Capital’s recent sell‑off of Anteris Technologies signals a strategic rebalancing in the health‑tech sector, and what investors should watch for.
4 minutes to read